Aryx Therapeutics I Stock Market Value

ARYX Stock  USD 0.0005  0.00  0.00%   
Aryx Therapeutics' market value is the price at which a share of Aryx Therapeutics trades on a public exchange. It measures the collective expectations of Aryx Therapeutics I investors about its performance. Aryx Therapeutics is trading at 5.0E-4 as of the 12th of January 2026; that is No Change since the beginning of the trading day. The stock's open price was 5.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Aryx Therapeutics I and determine expected loss or profit from investing in Aryx Therapeutics over a given investment horizon. Check out Aryx Therapeutics Correlation, Aryx Therapeutics Volatility and Aryx Therapeutics Alpha and Beta module to complement your research on Aryx Therapeutics.
Symbol

Please note, there is a significant difference between Aryx Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aryx Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aryx Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aryx Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aryx Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aryx Therapeutics.
0.00
06/21/2024
No Change 0.00  0.0 
In 1 year 6 months and 24 days
01/12/2026
0.00
If you would invest  0.00  in Aryx Therapeutics on June 21, 2024 and sell it all today you would earn a total of 0.00 from holding Aryx Therapeutics I or generate 0.0% return on investment in Aryx Therapeutics over 570 days. ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets More

Aryx Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aryx Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aryx Therapeutics I upside and downside potential and time the market with a certain degree of confidence.

Aryx Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Aryx Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aryx Therapeutics' standard deviation. In reality, there are many statistical measures that can use Aryx Therapeutics historical prices to predict the future Aryx Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aryx Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00050.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00040.00
Details
Naive
Forecast
LowNextHigh
0.00050.00050.0005
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00050.00050.0005
Details

Aryx Therapeutics Backtested Returns

We have found three technical indicators for Aryx Therapeutics I, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Aryx Therapeutics are completely uncorrelated.

Auto-correlation

    
  0.00  

No correlation between past and present

Aryx Therapeutics I has no correlation between past and present. Overlapping area represents the amount of predictability between Aryx Therapeutics time series from 21st of June 2024 to 2nd of April 2025 and 2nd of April 2025 to 12th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aryx Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Aryx Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Aryx Therapeutics lagged returns against current returns

Autocorrelation, which is Aryx Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aryx Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Aryx Therapeutics returns to help us make a trade decision. For example, suppose you find that Aryx Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Aryx Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aryx Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aryx Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aryx Therapeutics pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Aryx Therapeutics Lagged Returns

When evaluating Aryx Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aryx Therapeutics pink sheet have on its future price. Aryx Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aryx Therapeutics autocorrelation shows the relationship between Aryx Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Aryx Therapeutics I.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Aryx Pink Sheet Analysis

When running Aryx Therapeutics' price analysis, check to measure Aryx Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aryx Therapeutics is operating at the current time. Most of Aryx Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aryx Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aryx Therapeutics' price. Additionally, you may evaluate how the addition of Aryx Therapeutics to your portfolios can decrease your overall portfolio volatility.